Company intelligence / Profile preview

Wuhan Jingkang en Biomedical Technology

Wuhan, Hubei, China

Ownership: Private
Development stage: Other

Overview

Wuhan Jingkang Biomedical Technology is a specialized biotechnology company focused on the solid-state chemistry of pharmaceutical ingredients. The company provides high-end technical services including drug polymorph screening, salt formation studies, cocrystal screening, and crystallization process optimization. By leveraging advanced analytical techniques, Jingkang helps pharmaceutical companies improve the solubility, stability, and bioavailability of drug candidates. Their expertise supports both innovative drug development and the quality enhancement of generic medications.

Modalities: Small molecule
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Wuhan Jingkang en Biomedical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuhan Jingkang en Biomedical Technology.

Explore the full profile